At a glance
ClinicalIndex Comparison RecordN/ACompleted· 71 enrolled
Drug / intervention
The ivWatch Model 400device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ivWatch Model 400: Device Validation for Infiltrated Tissues
In Brief
A clinical study evaluating The ivWatch Model 400 for Infiltration of Peripheral IV Therapy. Completed, enrolled 71 participants across 1 site.
Detailed Summary
A single arm trial consisting of 70 adult volunteers to assess the safety and efficacy of the ivWatch Model 400 when observing infiltrated tissues at common sites for peripheral IV therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfiltration of Peripheral IV Therapy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2014
Primary CompletionFeb 2014
First PostedApr 2014
TodayJul 2026
First PostedApr 28, 2014
Enrollment StartFeb 1, 2014
Primary CompletionFeb 1, 2014
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 12.2 years ago
Interventions
The ivWatch Model 400device
The ivWatch Model 400 monitored the site during the course of the infiltration and issued red and/or yellow notifications if an infiltration was detected.